U.S. drug maker Eli Lilly & Co. is slashing the prices of its popular diabetes and weight-loss drugs Mounjaro and Zepbound by ...

Among growth ETFs, the Innovator IBD 50 ETFFFTY bounced 1.9%. The iShares Expanded Tech-Software Sector ETFIGV gained 1.4%, ...

Tesla is currently one of our top picks because it has finally broken out of a massive four-year base, signaling the ...

Nine large pharma companies have reached agreements with the Trump administration to lower certain drug prices in the U.S. | ...

The companies were the latest to agree to sell drugs to Medicaid and directly to consumers at discounted prices. President ...

Major stock indexes surged Thursday after delayed Consumer Price Index data came in better than expected, with the blue-chip ...

The Centers for Medicare & Medicaid Services Dec. 19 issued two proposed rules for implementing alternative drug pricing models.

Medicare enrollees will save more than 50% on out-of-pocket costs for 10 common prescription drugs under their insurance ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Genentech, Gilead, GSK, Merck, Novartis and Sanofi have agreed to drug pricing deals.

US President Donald Trump announced on Friday that nine drugmakers have agreed to lower the cost of their prescription drugs ...